| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | +100.0% |
| R&D Expense | $48.1M | -22.4% |
| SG&A Expense | $18.0M | -42.5% |
| Operating Income | -$66.1M | +34.8% |
| Interest Expense | $1.5M | +0.0% |
| Pre-tax Income | -$46.1M | +47.1% |
| Income Tax | $21K | — |
| Net Income | -$47.7M | +57.7% |
| EPS (Basic) | -$5.12 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $78.0M | +98.6% |
| Short-term Investments | $0 | — |
| Current Assets | $81.9M | -2.4% |
| Total Assets | $92.3M | +9.2% |
| Current Liabilities | $16.5M | +42.3% |
| Total Liabilities | $86.7M | +648.8% |
| Stockholders' Equity | $5.7M | -92.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.7M | +29.6% |
| Capital Expenditures | $75K | -67.1% |
| Investing Cash Flow | $19.9M | -80.3% |
| Financing Cash Flow | $95.1M | — |
| Free Cash Flow | -$67.8M | +29.7% |
| -162.6% |
| EPS (Diluted) | -$6.58 | -237.4% |